Skip to search formSkip to main contentSkip to account menu

CGP 28238

Known as: CGP-28238 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

flosulide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
The pharmacological profile of CGP 28238, a highly potent anti-inflammatory compound
CGP 28238 (6-(2,4-difluorophenoxy)-5-methylsulfonylamino-1-indanone ) exhibits very potent anti-inflammatory activity in rat… 
2005
2005
Inhibition of interleukin-1 (IL-1) enhanced pain reflexes in the rabbit by CGP 28238
CGP 28238 [6-(2,4-difluorophenoxy)-5-methylsulfonylamino-l-indanone] is a novel highly potent anti-inflammatory compound with… 
1999
1999
Interleukin-1beta-induced hyperresponsiveness to [Sar9,Met(O2)11]substance P in isolated human bronchi.
1998
1998
On the induction of cyclooxygenase-2, inducible nitric oxide synthase and soluble phospholipase A2 in rat mesangial cells by a nonsteroidal anti-inflammatory drug: the role of cyclic AMP.
One of the challenges in the therapy with anti-inflammatory drugs is the avoidance of gastrointestinal side effects, which may be… 
Highly Cited
1997
Highly Cited
1997
Role of prostaglandin H synthase-2-mediated conversion of arachidonic acid in controlling 3T6 fibroblast growth.
The specific role(s) of arachidonic acid (AA) and its metabolites in the signaling pathways that regulated fibroblast growth was… 
1997
1997
Role of prostaglandin H synthase-2-mediated conversion of arachidonic acid in controlling 3T6 fibroblast growth.
The specific role(s) of arachidonic acid (AA) and its metabolites in the signaling pathways that regulated fibroblast growth was… 
Highly Cited
1996
Highly Cited
1996
Cyclooxygenase-2-Dependent Bronchoconstriction in Perfused Rat Lungs Exposed to Endotoxin
BackgroundLipopolysaccharides (LPS), widely used to study the mechanisms of gram-negative sepsis, increase airway resistance by… 
Highly Cited
1994
Highly Cited
1994
Selective inhibition of cyclooxygenase 2.
1991
1991
Steroid-saving potency of nonsteroidal antiinflammatory agents--a reevaluation with the new agent CGP 28238 in rat inflammatory models.
The steroid-saving activity of the highly potent new non-steroid antiinflammatory agent CGP 28238 was determined in rat… 
1989
1989
The pharmacological profile of CGP 28238, a novel highly potent anti-inflammatory compound.
CGP 28238 (6-(2,4-difluorophenoxy)-5-methylsulfonylamino-1-indanone ) exhibits very potent anti-inflammatory activity in rat… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)